Poly-4-hydroxybutyrate (P4HB): a new generation of resorbable medical devices for tissue repair and regeneration

References

[1] Albertsmeier M, Seiler CM, Fischer L, et al. Evaluation of the safety and efficacy of MonoMax^® suture material for abdominal wall closure after primary midline laparotomy – a controlled prospective multicenter trial: ISSAAC [NCT005725079]. Langenbecks Arch Surg 2012; 397: 363–371.10.1007/s00423-011-0884-6Search in Google Scholar

[2] Angelos PC, Thakkar N, Sehgal A, Toriumi DM. Use of poly-4-hydroxybutyrate mesh in rhytidectomy: a retrospective review and cadaveric study of biomechanical strength testing. Presentation at the American Academy of Facial Plastic and Reconstructive Surgery Meeting, Washington DC, 2012.Search in Google Scholar

[3] Bohl A, Rohm HW, Ceschi P, et al. Development of a specially tailored local drug delivery system for the prevention of fibrosis after insertion of cochlear implants into the inner ear. J Mater Sci Mater Med 2012; 23: 2151–2162.10.1007/s10856-012-4698-zSearch in Google Scholar

[4] Bünger CM, Grabow N, Sternberg K, et al. A biodegradable stent based on poly(L-lactide) and poly(4-hydroxybutyrate) for peripheral vascular application: preliminary experience in the pig. J Endovasc Ther 2007; 14: 725–733.10.1177/152660280701400518Search in Google Scholar

[5] Martin DP, Badhwar A, Shah DV, et al. Characterization of poly-4-hydroxybutyrate mesh for hernia repair applications. J Surg Res 2013. Available at:http://dx.doi.org/10.1016/j.jss.2013.03.044.10.1016/j.jss.2013.03.044Search in Google Scholar

[6] Doi Y. Microbial polyesters. New York, NY, USA: VCH 1990.Search in Google Scholar

[7] Engelberg I, Kohn J. Physico-mechanical properties of degradable polymers used in medical applications: a comparative study. Biomaterials 1991; 12: 292–304.10.1016/0142-9612(91)90037-BSearch in Google Scholar

[8] FDA clears first of its kind suture made using DNA technology, FDA News Release, Silver Spring, MD, USA, February 12, 2007.Search in Google Scholar

[9] Grabow N, Bünger CM, Schultze C, et al. A biodegradable slotted tube stent based on poly(L-lactide) and poly(4-hydroxybutyrate) for rapid balloon-expansion. Ann Biomed Eng 2007; 35; 2031–2038.10.1007/s10439-007-9376-9Search in Google Scholar PubMed

[10] Hoerstrup S, Cummings I, Lachat M, et al. Functional growth in tissue-engineered living, vascular grafts: follow-up at 100 weeks in a large animal model. Circulation 2006; 114(Suppl I): I-159–I-166.10.1161/CIRCULATIONAHA.105.001172Search in Google Scholar PubMed

[11] Hoerstrup S, Sodian R, Daebritz S, et al. Functional living trileaflet heart valves grown in vitro. Circulation 2000; 102 (Suppl III): III-44–III-49.10.1161/01.CIR.102.suppl_3.III-44Search in Google Scholar PubMed

[12] Houk KN, Jabbari A, Hall HK, Alemn C. Why delta-valerolactone polymerizes and gamma-butyrolactone does not. J Org Chem 2008; 73: 2674–2678.10.1021/jo702567vSearch in Google Scholar PubMed

[13] Klouda L, Vaz CM, Mol A, Baaijens FPT, Bouten CVC. Effect of biomimetic conditions on mechanical and structural integrity of PGA/P4HB and electrospun PCL scaffolds. J Mater Sci Mater Med 2008; 19: 1137–1144.10.1007/s10856-007-0171-9Search in Google Scholar PubMed

[14] Löbler M, Sternberg K, Stachs O, et al. Polymers and drugs suitable for the development of a drug delivery drainage system in glaucoma surgery. J Biomed Mater Res Part B Appl Biomater 2011; 97B: 388–395.10.1002/jbm.b.31826Search in Google Scholar

[15] Lock J. BioTREK™: The first completely bioabsorbable closure device. Presentation at Congenital and Structural Interventions Conference, Frankfurt, Germany, July 9, 2009.Search in Google Scholar

[16] Martin DP, Williams SF. Medical applications of poly-4-hydroxybutyrate: a strong flexible absorbable biomaterial. Biochem Eng J 2003; 16: 97–105.10.1016/S1369-703X(03)00040-8Search in Google Scholar

[17] Matthews B, Deeken C. Characterization of the mechanical strength and resorption properties of a novel fully absorbable material (poly-4-hydroxybutyrate – Phasix™) in a porcine model of hernia repair. Hernia 2012; 16(Suppl 1): S60.10.1155/2013/238067Search in Google Scholar

[18] Nelson T, Kaufman E, Kline J, Sokoloff L. The extraneural distribution of gamma-hydroxybutyrate. J Neurochem 1981: 37: 1345–1348.10.1111/j.1471-4159.1981.tb04689.xSearch in Google Scholar

[19] Odermatt EK, Funk L, Bargon R, Martin DP, Rizk S, Williams SF. MonoMax suture: a new long-term absorbable monofilament suture made from poly-4-hydroxybutyrate. Int J Polym Sci 2012; 12, Article ID 216137.10.1155/2012/216137Search in Google Scholar

[20] Peschel G, Dahse H-M, Konrad A, et al. Growth of keratinocytes on porous films of poly(3-hydroxybutyrate) and poly(4-hydroxybutyrate) blended with hyaluronic acid and chitosan. J Biomed Mater Res A 2008; 85: 1072–1081.10.1002/jbm.a.31666Search in Google Scholar

[21] Petralli N. Facial volumetric replacement, the secret of youth. 28th Annual Scientific Meeting of the American Academy of Cosmetic Surgery, Pre-Conference Symposium, Las Vegas, USA, January 17, 2012.Search in Google Scholar

[22] Sendelbeck SL, Girdis CL. Disposition of a 14C-labeled bioerodible polyorthoester and its hydrolysis products, 4-hydroxybutyrate and cis, trans-1,4-bis(hydroxymethyl)cyclohexane in rats. Drug Metab Dispos 1985; 13: 291–295.Search in Google Scholar

[23] Shieh S-J, Terada S, Vacanti JP. Tissue engineering auricular reconstruction: in vitro and in vivo studies. Biomaterials 2004; 25: 1545–1557.10.1016/S0142-9612(03)00501-5Search in Google Scholar

[24] Stock U, Sakamoto T, Hatsuoka S, et al. Patch augmentation of the pulmonary artery with bioabsorbable polymers and autologous cell seeding. J Thorac Cardiovasc Surg 2000; 120: 1158–1167.10.1067/mtc.2000.109539Search in Google Scholar

[25] Tornier announces launch of BioFiber^® Surgical Mesh for tendon repair at arthroscopic surgery conference, Tornier Press Release, Edina, Minnesota, USA, http://www.tornier-us.com/news/press_view.php?pr_id=80, April 14, 2011.Search in Google Scholar

[26] Van de Velde K, Kiekens P. Biopolymers: overview of several properties and consequences on their applications. Polymer Testing 2002; 21: 433–442.10.1016/S0142-9418(01)00107-6Search in Google Scholar

[27] Weber B, Schoenauer R, Papadopulos F, et al. Engineering of living autologous human umbilical cord cell-based septal occlude membranes using composite PGA-P4HB matrices. Biomaterials 2011; 32: 9630–9641.10.1016/j.biomaterials.2011.07.070Search in Google Scholar PubMed

[28] Williams SF, Martin DP. Applications of PHAs in medicine and pharmacy. In: Doi Y, Steinbüchel A, editors. Weinheim, Germany: Biopolymers. Weinheim, Germany: Wiley-VCH 2002: 91–127.Search in Google Scholar

[29] Xeltis announces approval to begin first clinical study of its tissue-engineered vascular grafts, Xeltis press release, Zürich, Switzerland, http://www.businesswire.com/news/home/20111206005075/en/Xeltis-Announces-Approval-Clinical-Study-Tissue-Engineered-Vascular, December 6, 2011.Search in Google Scholar

[30] Xie H, Yashodhan YS, Shaffer BS. Chitosan hemostatic dressing for renal parenchymal wound sealing in a porcine model: implications for laparoscopic partial nephrectomy technique. JSLS 2008; 12: 18–24.Search in Google Scholar